Insiders who reported open-market trades in the last 12 months at the companies Joseph S. Konowiecki files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
John E. Kao - $54.16M in ALHC purchases and sales in the last 12 months
Joseph S. Konowiecki is a corporate insider, tracked as EVP, Corporate Affairs, Director of Alignment Healthcare, Inc. (ALHC). InsiderAlpha holds 16 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Joseph S. Konowiecki submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Joseph S. Konowiecki been buying or selling stock?
Recorded transactions: 0 open-market purchases and 12 open-market sales ($4.64M) across all tracked filings.
Joseph S. Konowiecki is EVP, Corporate Affairs, Director of Alignment Healthcare, Inc. (ALHC). 16 SEC Form 4 filings on record going back to 2024, most recently on 18 September 2026. Most recent open-market trade: sold $202K of ALHC on 18 September 2026. Lifetime open-market sales: $4.64M.
Recent transactions
16
The latest 16 SEC Form 4 transactions reported by Joseph S. Konowiecki.
InsiderAlpha's records for Joseph S. Konowiecki go back to 2024: 16 primary Form 4 filings, an average of 5.3 per year. 6 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
